Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 421

Showing 1-25 of 421 citing articles:

Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy
Mengze Lv, Meixia Chen, Rui Zhang, et al.
Cell Research (2020) Vol. 30, Iss. 11, pp. 966-979
Open Access | Times Cited: 575
Engineering nanomedicine for glutathione depletion-augmented cancer therapy
Yuxuan Xiong, Chen Xiao, Zifu Li, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 10, pp. 6013-6041
Closed Access | Times Cited: 483
Long noncoding RNAs in cancer metastasis
Siyuan Liu, Ha X. Dang, Daniel A. Lim, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 446-460
Open Access | Times Cited: 482
Neoantigens: promising targets for cancer therapy
Na Xie, Guobo Shen, Wei Gao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 364
Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma
Qunxing Li, Xiangqi Liu, Dikan Wang, et al.
International Journal of Oral Science (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 218
CD4+ T cells in cancer
Daniel E. Speiser, Obinna Chijioke, Karin Schaeuble, et al.
Nature Cancer (2023) Vol. 4, Iss. 3, pp. 317-329
Closed Access | Times Cited: 204
Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer
Zirui Zhao, Haohan Liu, Xingyu Zhou, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-16
Open Access | Times Cited: 171
Glial and myeloid heterogeneity in the brain tumour microenvironment
Brian M. Andersen, Camilo Faust Akl, Michael A. Wheeler, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 12, pp. 786-802
Open Access | Times Cited: 138
NK cell infiltration is associated with improved overall survival in solid cancers: A systematic review and meta-analysis
Sarah Nersesian, Sarah L. Schwartz, Stephanie R. Grantham, et al.
Translational Oncology (2020) Vol. 14, Iss. 1, pp. 100930-100930
Open Access | Times Cited: 133
Astragalus polysaccharide: a review of its immunomodulatory effect
Chunxiao Li, Ying Liu, Yuzhen Zhang, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 6, pp. 367-389
Closed Access | Times Cited: 133
A pan-cancer single-cell panorama of human natural killer cells
Fei Tang, Jinhu Li, Lu Qi, et al.
Cell (2023) Vol. 186, Iss. 19, pp. 4235-4251.e20
Open Access | Times Cited: 131
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 130
Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial
David Marín, Ye Li, Rafet Başar, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 772-784
Open Access | Times Cited: 122
Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis
Rongqing Pan, Jeremy Ryan, Deng Pan, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1521-1538.e18
Open Access | Times Cited: 121
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y. Chiang, Ira Mellman
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004711-e004711
Open Access | Times Cited: 113
Natural killer cells: a promising immunotherapy for cancer
Chu J, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 106
Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy
Qiang Lü, Dongquan Kou, Shenghan Lou, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 104
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Zhaoting Li, Yixin Wang, Yingyue Ding, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 23
Closed Access | Times Cited: 100
Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
Wanjia Tian, Ningjing Lei, Junying Zhou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 89
PD-1/PD-L1 checkpoint inhibitors in advanced hepatocellular carcinoma immunotherapy
Qian Li, Jingjing Han, Yonglin Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 86
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 84
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells
Sumit Sen Santara, Dian-Jang Lee, Ângela C. Crespo, et al.
Nature (2023) Vol. 616, Iss. 7956, pp. 348-356
Open Access | Times Cited: 75
Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy
Reza Hosseini, Hamzeh Sarvnaz, Maedeh Arabpour, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 70
Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma
Daniel S. Kirschenbaum, Kaikun Xie, Florian Ingelfinger, et al.
Cell (2023) Vol. 187, Iss. 1, pp. 149-165.e23
Closed Access | Times Cited: 69
NK cells are never alone: crosstalk and communication in tumour microenvironments
Yongqiang Zhou, Cheng Lu, Lu Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top